|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
$0.00 0.00 (0.00%) as of 4:30 Mon 5/6
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq Small Cap |
| Security
Type: |
N/A |
| Shares
Out: |
239,210,000 |
| Market
Cap: |
478.42(K) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0.000001 - $1.17 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Amyris is a biotechnology company. Co. creates, manufactures and commercializes consumer products and ingredients. Co.'s ingredients and consumer products are powered by its fermentation-based Lab-to-Market™ technology platform. Co. has produced a renewable farnesene brand, Biofene®, a long-chain, branched hydrocarbon molecule that Co. manufactures through fermentation using engineered microbes. Co. has formulated its fermentation-based ingredients such as Squalane, Hemisqualane™, and Steviol Glycoside Rebaudioside M into its consumer brands. Co.'s consumer brands include: Biossance® clean beauty skincare, Pipette® clean baby skincare, and Purecane™ sweetener.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
17,155 |
| Total Buy Value |
$0 |
$0 |
$0 |
$69,135 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
0 |
0 |
0 |
4,354,080 |
| Total Sell Value |
$0 |
$0 |
$0 |
$15,807,372 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
12 |
| End Date |
2024-03-24 |
2023-12-22 |
2023-06-23 |
2022-06-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Boisseau Philippe |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
17,000 |
|
- |
|
| Reinach Fernando De Castro |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
32,000 |
|
- |
|
| Al Thani Sheikh Abdullah Bin Khalifa |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
29,000 |
|
- |
|
| Duyk Geoffrey M |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
29,000 |
|
- |
|
| Piwnica Carole |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
32,000 |
|
- |
|
| Doerr L John |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
32,000 |
|
- |
|
| Georgiadis Mary Margaret Hastings |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
47,000 |
|
- |
|
| Klaeijsen Abraham |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
20,000 |
|
- |
|
| Williams R Neil |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
26,000 |
|
- |
|
| Yang Patrick Y |
Director |
– • – |
2016-07-13 |
4 |
A |
$0.00 |
$0 |
D/D |
17,000 |
53,000 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2016-06-14 |
4 |
S |
$1.04 |
$208,600 |
D/D |
(200,577) |
1,108,333 |
|
- |
|
| Doerr L John |
Director |
– • – |
2016-06-14 |
4 |
B |
$1.04 |
$208,600 |
I/I |
200,577 |
13,037,586 |
2.1 |
- |
|
| Weaver Karen |
Principal Accounting Officer |
• – – |
2016-06-01 |
4 |
D |
$0.54 |
$90 |
D/D |
(167) |
75,135 |
|
- |
|
| Cherry Joel |
President of R&D |
• – – |
2016-06-01 |
4 |
D |
$0.54 |
$7,441 |
D/D |
(13,779) |
617,873 |
|
- |
|
| Khadder Nicholas |
General Counsel and Secretary |
• – – |
2016-06-01 |
4 |
D |
$0.54 |
$6,602 |
D/D |
(12,226) |
402,020 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2016-06-01 |
4 |
D |
$0.54 |
$28,749 |
D/D |
(53,238) |
1,308,910 |
|
- |
|
| Cherry Joel |
President of R&D |
• – – |
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
200,000 |
631,652 |
|
- |
|
| Khadder Nicholas |
General Counsel and Secretary |
• – – |
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
414,246 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
425,000 |
1,362,148 |
|
- |
|
| Weaver Karen |
Principal Accounting Officer |
• – – |
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
37,500 |
75,302 |
|
- |
|
| Asadorian Raffi |
Chief Financial Officer |
• – – |
2016-05-16 |
4 |
A |
$0.00 |
$0 |
D/D |
100,000 |
270,834 |
|
- |
|
| Cherry Joel |
President of R&D |
• – – |
2016-04-01 |
4 |
D |
$1.09 |
$27,179 |
D/D |
(24,935) |
431,652 |
|
- |
|
| Khadder Nicholas |
General Counsel and Secretary |
• – – |
2016-04-01 |
4 |
D |
$1.09 |
$6,486 |
D/D |
(5,950) |
264,246 |
|
- |
|
| Melo John |
President and CEO |
• • – |
2016-04-01 |
4 |
D |
$1.09 |
$73,595 |
D/D |
(67,518) |
937,148 |
|
- |
|
| Weaver Karen |
Principal Accounting Officer |
• – – |
2016-04-01 |
4 |
D |
$1.09 |
$1,431 |
D/D |
(1,313) |
37,802 |
|
- |
|
406 Records found
|
|
Page 14 of 17 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
